Brad was most recently Chief Medical Officer at RenaMed Biologics. Prior to that, he was Vice President, Clinical Development at Amgen, where he was responsible for clinical development within the Anemia/Nephrology therapeutic area. He had previously spent ten years at Emory University conducting basic and clinical research.
